LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.62 | 21.74 | 3132 | 4150 | 0.7545 | 0.9270 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.59 | 21.74 | 286 | 4492 | 0.0637 | 0.3980 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.59 | 21.74 | 3287 | 4492 | 0.7317 | 0.9204 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.59 | 21.74 | 46 | 4492 | 0.0102 | 0.1024 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.59 | 21.74 | 3420 | 4492 | 0.7613 | 0.9303 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.56 | 21.74 | 345 | 4838 | 0.0713 | 0.4255 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.56 | 21.74 | 3584 | 4838 | 0.7407 | 0.9245 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.56 | 21.74 | 58 | 4838 | 0.0120 | 0.1341 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.56 | 21.74 | 3754 | 4838 | 0.7758 | 0.9360 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.53 | 21.74 | 465 | 5150 | 0.0903 | 0.4745 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.53 | 21.74 | 3867 | 5150 | 0.7508 | 0.9286 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.53 | 21.74 | 81 | 5150 | 0.0157 | 0.1815 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.53 | 21.74 | 4129 | 5150 | 0.8016 | 0.9447 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.50 | 21.74 | 525 | 5425 | 0.0968 | 0.4916 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.50 | 21.74 | 4207 | 5425 | 0.7754 | 0.9371 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.50 | 21.74 | 87 | 5425 | 0.0160 | 0.1902 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 53.50 | 21.74 | 4398 | 5425 | 0.8106 | 0.9479 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 21.74 | 596 | 5768 | 0.1033 | 0.5087 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 21.74 | 4503 | 5768 | 0.7806 | 0.9394 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 21.74 | 155 | 5768 | 0.0269 | 0.2763 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 55.48 | 21.74 | 4640 | 5768 | 0.8043 | 0.9466 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.45 | 21.74 | 648 | 6023 | 0.1076 | 0.5195 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.45 | 21.74 | 4808 | 6023 | 0.7982 | 0.9452 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.45 | 21.74 | 159 | 6023 | 0.0264 | 0.2779 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 57.45 | 21.74 | 4992 | 6023 | 0.8287 | 0.9542 | MN20160310_N01 | K13 |